November 27, 2019

REBEL Core Cast 22.0 – Decompensated Liver Disease

Take Home Points   

  • End stage liver disease patients have fragile baseline physiology. Minor insults can have profound effects
  • Always start with the basics – large bore IV lines
  • SBP give 3rd generation cephalosporin + albumin in severe disease
  • Upper GI bleed give appropriate blood products + ceftriaxone

 

REBEL Core Cast 22.0 – Decompensated Liver Disease

Click here for Direct Download of Podcast

What does the liver do

  • Makes most of macrophages and complement proteins
  • Produces clotting factors and fibrinogen and Protein C & S and antithrombin
  • Produces albumin – creates oncotic gradient

Cirrhosis

  • Represents a late stage of progressive hepatic fibrosis characterized by distortion of the hepatic architecture
  • Essential functions of liver compromised – immunocompromised, vasodilated, hyperdynamic cardiac function at baseline. Not healthy patients!!

Things to consider in presentation of cirrhotic patients

  • Consider them all immunocompromised!
    • May lack fever, leukocytosis on presentation – presume they’re all sick
  • Ask yourself why they’re coming in
    • Increasing ascites – why is it getting bigger?
    • Hepatic encephalopathy – don’t just treat elevated ammonia, ask why it’s happening
  • Calculate Shock Index – HR / SBP
    • > 0.7 – abnormal
    • > 1.0 – worrisome
    • Can clue you into patient being hypovolemic before they become hypotensive.
    • Note: Many patients are on beta blockers which can mask tachycardia

Access

  • These patients can be tough vascular access
  • Central line is not your best bet, get short, fat catheters for great flow rates.
  • If you can’t get IV access, get an IO in there

Spontaneous bacterial peritonitis

  • Suspect in all patients with ascites
  • Classic triad of fever, ascites and abdominal pain is rarely present
  • New renal failure, diarrhea, hypothermia and acidosis are potential presentations
  • 13% will present with no symptoms at all!!
  • Have a low threshold to tap
    • >250 PMN is main diagnostic criteria, also send for cultures
  • Management
    • 3rd generation cephalosporin (ceftriaxone or cefotaxime)
      • Ceftriaxone 25 mg/kg up to 2 gm daily
      • Cefotaxime 25 mg/kg up to 1 gm Q8
    • 1.5g/kg of albumin
      • Benefit of albumin is in patient with severe disease with creatinine >1, BUN > 30 or total bili > 4
    • Albumin + Antibiotic had 20% reduction in renal failure and a 25% reduction in mortality

GI Bleed

  • Cirrhotic patients develop varices at rate of 5-15% per year
  • Management
    • 2 Large Bore IVs
    • Emergency Type O from the beginning
      • Call for 4 Units immediately then switch to type specific
      • Consider massive transfusion protocol
      • O negative for women of child bearing age, O positive for all others
  • Send off TEG to help guide resuscitation
  • If no TEG, send Fibrinogen level
    • Fibrinogen <100:  give cryoprecipitate
  • Secure airway – consider delayed sequence intubation
    • Delayed sequence will allow you to preoxygenate, suction and drop NG tube to decompress GI tract
    • Ketamine 0.5 mg/kg IV
  • Get Blakemore or Minnesota tube ready
  • Octreotide and PPI do not affect these patients mortality
  • Give antibiotic!
    • Ceftriaxone or other 3rd generation cephalosporin
    • NNT of 4 for preventing infection
    • NNT of 22 for reducing mortality

Links & Resources:

Shownotes Written By: Miguel Reyes, MD (Twitter: @miguel_reyesMD)

Post Peer Reviewed By: Salim R. Rezaie, MD (Twitter: @srrezaie)

Cite this article as: Anand Swaminathan, "REBEL Core Cast 22.0 – Decompensated Liver Disease", REBEL EM blog, November 27, 2019. Available at: https://rebelem.com/rebel-core-cast-22-0-decompensated-liver-disease/.
The following two tabs change content below.

Anand Swaminathan

Clinical Assistant Professor of Emergency Medicine at St. Joe's Regional Medical Center (Paterson, NJ)
REBEL EM Associate Editor and Author

Latest posts by Anand Swaminathan (see all)

2 Comments

Post A Comment

Time limit is exhausted. Please reload CAPTCHA.

0